World Health Day

Today, World Health Day is being celebrated all over the world.On the occasion of this day, I would like to share with you information about Depressive Disease
According to WHO Prevalence of Depression in Pakistan is 4.2%of the total population
In Major Depressive Disorder
Escitalopram Cipralex international brand has superior efficasy compared to SSRI and SNRI as well as superior in Rate of Response and Remission
BJGP. Escitalopram Cipralex is the First Line Treatment for Depression
Better Safety in
Depression with Hepatitis C
Escitalopram Cipralex is safe effective and well tolerated in the treatment of Depression with Co-morbid mild to moderate Hepatitis C
Depression With Diabetes Mellitus
Depression worsens the prognosis of diabetes increase non-compliance to the medical treatment
Escitalopram Cipralex Effective in treating depression in patients with diabetes mellitus and has beneficial effective on Glycemic Control
Escitalopram Cipralex has superior efficasy compared to SSRI and SNRI in Major Depressive Disorder
Escitalopram Cipralex superior in Rate of Response and Remission as compare to SSRI and SNRI
Escitalopram Cipralex is safe effective and well tolerated in the treatment of Depression with Hepatitis C
Escitalopram Cipralex is the First Line Treatment for Depression by several International Guidelines